伊戈爾(002922.SZ)擬定增募資不超4.79億元 用於光伏發電併網設備智能製造項目等
格隆匯3月24日丨伊戈爾(002922.SZ)披露2020年度非公開發行股票預案,擬非公開發行股票數量不超過此次發行前公司總股本的30%,即不超過4054.5442萬股(含本數)。
此次發行的全部發行對象均以現金方式、以相同價格認購此次發行的股票。其中,肖俊承以現金方式、按照與其他認購對象相同的認購價格認購,並承諾不參與競價過程且接受最終確定的發行價格,認股款總額不低於4000萬元。
募集資金總額不超過約4.79億元,扣除發行費用後,約3.855億元用於光伏發電併網設備智能製造項目,9380萬元用於償還銀行貸款及補充流動資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.